Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wonshik Han

Showing results (221-230 of 399) with videos related to

Pageof 40
Sort By:
Familial Cancer|August 12, 2009
Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean populationMoon-Woo Seong, Sung Im Cho, Dong-Young Noh, et al.
Developmental Cell|February 21, 2012
BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylationEunhee Choi, Pil-Gu Park, Hae-Ock Lee, et al.
Frontiers in Oncology|July 19, 2021
Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast CancerSungchan Gwark, Sei Hyun Ahn, Woo Chul Noh, et al.
Frontiers in Oncology|October 18, 2021
Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast CancerSungchan Gwark, Woo Chul Noh, Sei Hyun Ahn, et al.
Journal of Breast Cancer|July 12, 2014
Low rates of additional cancer detection by magnetic resonance imaging in newly diagnosed breast cancer patients who undergo preoperative mammography and ultrasonographyJisun Kim, Wonshik Han, Hyeong-Gon Moon, et al.
Journal of Breast Cancer|February 26, 2021
Association between Number of Retrieved Sentinel Lymph Nodes and Breast Cancer-related LymphedemaHong Kyu Kim, Young Wook Ju, Jun Woo Lee, et al.
Journal of Breast Cancer|April 30, 2024
Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent ResponseJai Min Ryu, Hyunjun Lee, Wonshik Han, et al.
Breast (Edinburgh, Scotland)|July 4, 2012
Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excisionJisun Kim, Wonshik Han, Jong Won Lee, et al.
Clinical Therapeutics|July 20, 2010
Cost-effectiveness analysis of 5 years of postoperative adjuvant tamoxifen therapy for Korean women with breast cancer: retrospective cohort study of the Korean breast cancer society databaseJae Jeong Yang, Sue K Park, Lisa Y Cho, et al.
Breast Cancer Research and Treatment|July 4, 2012
Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy: distinct patterns of response according to ER expressionHyeong-Gon Moon, Seock-Ah Im, Wonshik Han, et al.
Pageof 40

Showing results (221-230 of 399) with videos related to

Sort By:
Pageof 40
Familial Cancer|August 12, 2009
Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean populationMoon-Woo Seong, Sung Im Cho, Dong-Young Noh, et al.
Developmental Cell|February 21, 2012
BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylationEunhee Choi, Pil-Gu Park, Hae-Ock Lee, et al.
Frontiers in Oncology|July 19, 2021
Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast CancerSungchan Gwark, Sei Hyun Ahn, Woo Chul Noh, et al.
Frontiers in Oncology|October 18, 2021
Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast CancerSungchan Gwark, Woo Chul Noh, Sei Hyun Ahn, et al.
Journal of Breast Cancer|July 12, 2014
Low rates of additional cancer detection by magnetic resonance imaging in newly diagnosed breast cancer patients who undergo preoperative mammography and ultrasonographyJisun Kim, Wonshik Han, Hyeong-Gon Moon, et al.
Journal of Breast Cancer|February 26, 2021
Association between Number of Retrieved Sentinel Lymph Nodes and Breast Cancer-related LymphedemaHong Kyu Kim, Young Wook Ju, Jun Woo Lee, et al.
Journal of Breast Cancer|April 30, 2024
Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent ResponseJai Min Ryu, Hyunjun Lee, Wonshik Han, et al.
Breast (Edinburgh, Scotland)|July 4, 2012
Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excisionJisun Kim, Wonshik Han, Jong Won Lee, et al.
Clinical Therapeutics|July 20, 2010
Cost-effectiveness analysis of 5 years of postoperative adjuvant tamoxifen therapy for Korean women with breast cancer: retrospective cohort study of the Korean breast cancer society databaseJae Jeong Yang, Sue K Park, Lisa Y Cho, et al.
Breast Cancer Research and Treatment|July 4, 2012
Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy: distinct patterns of response according to ER expressionHyeong-Gon Moon, Seock-Ah Im, Wonshik Han, et al.
Pageof 40